Heike Künzel - Concepedia

Author

Heike Künzel

Also Known As

H E Künzel, H Künzel, H. E. Künzel, H. KÜNZEL, H. Künzel, H.E. Künzel, HE Künzel, Heike E Künzel, Heike E. Kunzel, Heike E. Künzel

Publications

5.3K

Citations

H-Index

Concepts

All Affiliations

Max Planck Institute of Psychiatry Ludwig-Maximilians-Universität München Max Planck Society LMU Klinikum Helmholtz Zentrum München

About

Heike Künzel is an author at Max Planck Institute of Psychiatry specializing in medicine, psychiatry, and psychopathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	26	3.7K
2	Social Sciences	16	16	3.1K
3	Endocrinology	9	9	1.4K
4	Health Sciences	2	2	150
5	Diabetes	2	2	32

Heike Künzel

Publications

4.6K

Citations

H-Index

Page 1

	Year	Citations
Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment Elisabeth B. Binder, Daria Salyakina, Peter Lichtner, Nature Genetics PsychopathologyPsychiatryMood SymptomGeneticsPsychiatric Genetics	2004	970
Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated Astrid Zobel, Thomas Nickel, Heike Künzel, Journal of Psychiatric Research Stress HormonePsychiatryMood SymptomMedicineAntagonist R121919	2000	704
Combined Dexamethasone/Corticotropin Releasing Hormone Test Predicts Treatment Response in Major Depression–A Potential Biomarker? Marcus Ising, Sonja Horstmann, Stefan Kloiber, Biological Psychiatry PsychiatryMood SymptomDepressionDepression PathogenesisSocial Sciences	2006	337
Clinical characteristics and treatment outcome in a representative sample of depressed inpatients – Findings from the Munich Antidepressant Response Signature (MARS) project Johannes M. Hennings, Toshimi Owashi, Elisabeth B. Binder, Journal of Psychiatric Research Treatment OutcomeRepresentative SamplePsychiatryMood SymptomClinical Characteristics	2008	179
Impaired divided attention predicts delayed response and risk to relapse in subjects with depressive disorders Matthias Majer, Marcus Ising, Heike Künzel, Psychological Medicine	2004	176
Hypothalamus-pituitary-adrenal system regulation and suicidal behavior in depression Andrea Pfennig, Heike Künzel, Nikola Kern, Biological Psychiatry Stress HormonePsychiatryMood SymptomMedicineSuicide	2005	151
Pharmacological and Nonpharmacological Factors Influencing Hypothalamic–Pituitary–Adrenocortical Axis Reactivity in Acutely Depressed Psychiatric In-patients, Measured by the Dex-CRH Test Heike Künzel, Elisabeth B. Binder, Thomas Nickel, Neuropsychopharmacology Psychiatric In-patientsStress HormonePsychiatryMedicineDex-crh Test	2003	143
High-Affinity CRF1 Receptor Antagonist NBI-34041: Preclinical and Clinical Data Suggest Safety and Efficacy in Attenuating Elevated Stress Response Marcus Ising, U. Zimmermann, Heike Künzel, Neuropsychopharmacology InflammationPsychoneuroimmunologyStress HormoneFunctional SelectivityStress	2007	138
Treatment of depression with the CRH-1-receptor antagonist R121919: endocrine changes and side effects Heike Künzel, Astrid Zobel, Thomas Nickel, Journal of Psychiatric Research Molecular PharmacologyEndocrine ChangesStress HormonePsychiatryMood Symptom	2003	134
Treatment with the CRH1-receptor-antagonist R121919 improves sleep-EEG in patients with depression K. Held, Heike Künzel, Marcus Ising, Journal of Psychiatric Research Sleep MedicineSleepSleep DisordersSleep DisorderPsychiatry	2003	125

Page 1